Viatris Net Profit Margin 2010-2024 | VTRS

Current and historical net profit margin for Viatris (VTRS) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Viatris net profit margin for the three months ending September 30, 2024 was .
Viatris Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $15.05B $-0.88B -5.87%
2024-06-30 $15.24B $-0.65B -4.24%
2024-03-31 $15.36B $-0.06B -0.36%
2023-12-31 $15.43B $0.05B 0.36%
2023-09-30 $15.47B $1.83B 11.85%
2023-06-30 $15.60B $1.85B 11.88%
2023-03-31 $15.80B $1.90B 12.05%
2022-12-31 $16.26B $2.08B 12.78%
2022-09-30 $16.73B $0.80B 4.80%
2022-06-30 $17.19B $0.76B 4.43%
2022-03-31 $17.65B $0.17B 0.95%
2021-12-31 $17.89B $-1.27B -7.09%
2021-09-30 $17.17B $-1.92B -11.19%
2021-06-30 $15.60B $-2.05B -13.12%
2021-03-31 $13.76B $-1.73B -12.57%
2020-12-31 $11.95B $-0.67B -5.61%
2020-09-30 $11.51B $0.27B 2.32%
2020-06-30 $11.50B $0.27B 2.36%
2020-03-31 $11.63B $0.06B 0.54%
2019-12-31 $11.50B $0.02B 0.15%
2019-09-30 $11.39B $0.05B 0.41%
2019-06-30 $11.29B $0.03B 0.30%
2019-03-31 $11.25B $0.24B 2.14%
2018-12-31 $11.43B $0.35B 3.09%
2018-09-30 $11.59B $0.55B 4.71%
2018-06-30 $11.72B $0.46B 3.90%
2018-03-31 $11.87B $0.72B 6.03%
2017-12-31 $11.91B $0.70B 5.84%
2017-09-30 $11.94B $0.87B 7.28%
2017-06-30 $12.01B $0.66B 5.51%
2017-03-31 $11.61B $0.53B 4.58%
2016-12-31 $11.08B $0.48B 4.33%
2016-09-30 $10.30B $0.26B 2.50%
2016-06-30 $9.94B $0.81B 8.11%
2016-03-31 $9.75B $0.81B 8.27%
2015-12-31 $9.43B $0.85B 9.00%
2015-09-30 $9.02B $0.84B 9.34%
2015-06-30 $8.41B $0.91B 10.85%
2015-03-31 $7.88B $0.87B 11.05%
2014-12-31 $7.72B $0.93B 12.03%
2014-09-30 $7.45B $0.92B 12.36%
2014-06-30 $7.13B $0.58B 8.14%
2014-03-31 $6.99B $0.63B 9.05%
2013-12-31 $6.91B $0.62B 9.03%
2013-09-30 $6.82B $0.61B 8.88%
2013-06-30 $6.86B $0.66B 9.59%
2013-03-31 $6.85B $0.62B 9.04%
2012-12-31 $6.80B $0.64B 9.43%
2012-09-30 $6.61B $0.61B 9.21%
2012-06-30 $6.38B $0.55B 8.68%
2012-03-31 $6.27B $0.56B 8.95%
2011-12-31 $6.13B $0.54B 8.74%
2011-09-30 $6.03B $0.41B 6.80%
2011-06-30 $5.81B $0.36B 6.21%
2011-03-31 $5.61B $0.27B 4.74%
2010-12-31 $5.45B $0.22B 4.09%
2010-09-30 $5.37B $0.22B 4.17%
2010-06-30 $5.28B $0.08B 1.44%
2010-03-31 $5.18B $0.08B 1.60%
2009-12-31 $5.09B $0.09B 1.83%
Sector Industry Market Cap Revenue
Medical Medical Services $15.958B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.361B 11.58
Cencora (COR) United States $48.280B 17.81
DiDi Global (DIDIY) China $22.212B 0.00
Natera (NTRA) United States $22.082B 0.00
ICON (ICLR) Ireland $17.675B 15.74
Avantor (AVTR) United States $14.143B 21.20
Revvity (RVTY) United States $13.634B 23.68
CochLear (CHEOY) Australia $12.777B 0.00
Solventum (SOLV) United States $12.233B 0.00
BioMerieux (BMXMF) France $11.895B 0.00
Medpace Holdings (MEDP) United States $10.498B 29.58
Charles River Laboratories (CRL) United States $10.011B 19.34
HealthEquity (HQY) United States $9.104B 49.41
Doximity (DOCS) United States $8.999B 52.97
Sonic Healthcare (SKHHY) Australia $8.862B 0.00
Bausch + Lomb (BLCO) Canada $6.892B 32.08
Life Times (LTH) United States $5.081B 33.63
Organon (OGN) United States $3.935B 3.97
Sotera Health (SHC) United States $3.631B 19.42
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.925B 33.35
Concentras Parent (CON) United States $2.789B 0.00
PACS (PACS) United States $2.515B 0.00
Alignment Healthcare (ALHC) United States $2.310B 0.00
Ardent Health Partners (ARDT) United States $2.259B 0.00
Premier (PINC) United States $2.195B 11.42
GeneDx Holdings (WGS) United States $2.162B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GoodRx Holdings (GDRX) United States $1.868B 49.00
Teladoc Health (TDOC) United States $1.828B 0.00
Progyny (PGNY) United States $1.315B 26.62
Pediatrix Medical (MD) United States $1.285B 12.57
CareDx (CDNA) United States $1.241B 0.00
Establishment Labs Holdings (ESTA) $1.206B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 6.66
Embecta (EMBC) United States $0.797B 5.32
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.779B 0.00
SBC Medicals (SBC) United States $0.674B 0.00
InnovAge Holding (INNV) United States $0.662B 0.00
Auna S.A (AUNA) Luxembourg $0.522B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
DocGo (DCGO) United States $0.434B 16.35
Enhabit (EHAB) United States $0.380B 32.87
COMPASS Pathways (CMPS) United Kingdom $0.302B 0.00
ModivCare (MODV) United States $0.254B 13.79
LifeMD (LFMD) United States $0.251B 0.00
Sera Prognostics (SERA) United States $0.221B 0.00
Biodesix (BDSX) United States $0.186B 0.00
Nutex Health (NUTX) United States $0.179B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
MultiPlan (MPLN) United States $0.112B 0.00
So-Young (SY) China $0.086B 16.60
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.041B 1.10
IceCure Medical (ICCM) Israel $0.032B 0.00
Co-Diagnostics (CODX) United States $0.032B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.021B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00